{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:31:30Z","timestamp":1787725890489,"version":"build-2784847793"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute kidney injury remains clinically relevant after transcatheter aortic valve implantation (TAVI), particularly in chronic kidney disease, and iodinated contrast is a modifiable procedural contributor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective single-center study of 50 patients undergoing transfemoral TAVI with an intraprocedural ultra\u2013low-contrast strategy using the MyVal transcatheter heart valve. The primary feasibility endpoint was successful TAVI completion with total intraprocedural contrast volume \u226410\u2005mL. Procedural outcomes, valve performance, renal function, and 30-day clinical events were assessed. Contrast-enhanced cardiac CT angiography was used for planning. Median CT contrast volume was 45\u2005mL; median CT-to-TAVI interval was 18 days. Exploratory 6-month renal and clinical follow-up was analyzed when available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ultra\u2013low-contrast MyVal TAVI was completed in all patients, with median contrast volume 8\u2005mL [interquartile range, 6\u201310] and no procedure exceeding 10\u2005mL. Baseline renal impairment was frequent, with median estimated glomerular filtration rate 38\u2005mL\/min\/1.73\u2005m\n                      <jats:sup>2<\/jats:sup>\n                      and 15 patients having estimated glomerular filtration rate &amp;lt;30\u2005mL\/min\/1.73\u2005m\n                      <jats:sup>2<\/jats:sup>\n                      . Technical success was achieved in 50 patients, with no intraprocedural death, coronary obstruction, annular rupture, valve embolization, second valve implantation, or emergency surgery. Valve hemodynamics improved, with mean aortic gradient decreasing from 45.2\u2009\u00b1\u200911.8\u2005mmHg at baseline to 8.7\u2009\u00b1\u20093.2\u2005mmHg at 30 days, and no moderate or severe paravalvular regurgitation. Renal function remained stable, with no significant creatinine increase and modest estimated glomerular filtration rate increase at 30 days. Acute kidney injury occurred in 1 patient and was limited to stage 1; no patient developed stage 2 or 3 acute kidney injury or required new renal replacement therapy. Among patients with 6-month laboratory follow-up, renal function remained stable or improved, and no patient initiated renal replacement therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this single-center feasibility study, an intraprocedural ultra\u2013low-contrast transfemoral TAVI strategy using the MyVal valve was feasible, with preserved early procedural success and valve performance. Renal function remained stable through 30 days, and AKI was infrequent; however, without a comparator group, these findings should be interpreted as descriptive feasibility and early safety observations rather than evidence of renal protection, AKI reduction, or superiority over standard contrast-guided TAVI. Larger comparative studies are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1878620","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:03:30Z","timestamp":1787724210000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Ultra\u2013low-contrast transfemoral TAVI using the MyVal transcatheter heart valve: a prospective single-center feasibility and safety study"],"prefix":"10.3389","volume":"13","author":[{"given":"Georgios E.","family":"Papadopoulos","sequence":"first","affiliation":[{"name":"Cardiology Department, Interbalkan Medical Center","place":["Thessaloniki, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Ninios","sequence":"additional","affiliation":[{"name":"Cardiology Department, Interbalkan Medical Center","place":["Thessaloniki, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kalaitzoglou","sequence":"additional","affiliation":[{"name":"Cardiology Department, Interbalkan Medical Center","place":["Thessaloniki, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Evangelou","sequence":"additional","affiliation":[{"name":"Cardiology Department, Interbalkan Medical Center","place":["Thessaloniki, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ioannides","sequence":"additional","affiliation":[{"name":"Cardiology Department, Interbalkan Medical Center","place":["Thessaloniki, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athinodoros","family":"Nikitopoulos","sequence":"additional","affiliation":[{"name":"Cardiology Department, Interbalkan Medical Center","place":["Thessaloniki, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Bompas","sequence":"additional","affiliation":[{"name":"Cardiology Department, Interbalkan Medical Center","place":["Thessaloniki, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlasis","family":"Ninios","sequence":"additional","affiliation":[{"name":"Cardiology Department, Interbalkan Medical Center","place":["Thessaloniki, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Giamouzis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly","place":["Larissa, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/CIR.0000000000000932","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e024589","DOI":"10.1161\/JAHA.121.024589","article-title":"Acute kidney injury after transcatheter aortic valve replacement mediates the effect of chronic kidney disease","volume":"11","author":"Crimi","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3978\/j.issn.2072-1439.2015.06.14","article-title":"Acute kidney injury after transcatheter aortic valve implantation","volume":"7","author":"Scherner","year":"2015","journal-title":"J Thorac Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.4244\/EIJ-D-15-00254","article-title":"Predictors and outcome of acute kidney injury after transcatheter aortic valve implantation: a systematic review and meta-analysis","volume":"12","author":"Liao","year":"2017","journal-title":"EuroIntervention"},{"key":"B7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.carrev.2017.02.011","article-title":"The ratio of contrast volume to glomerular filtration rate predicts acute kidney injury and mortality after transcatheter aortic valve implantation","volume":"18","author":"Giannini","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jcin.2013.02.007","article-title":"Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation","volume":"6","author":"Yamamoto","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.3390\/jcm13102971","article-title":"Contrast volume-to-estimated glomerular filtration rate ratio as a predictor of short-term outcomes following transcatheter aortic valve implantation","volume":"13","author":"Chehab","year":"2024","journal-title":"J Clin Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1175600","DOI":"10.3389\/fcvm.2023.1175600","article-title":"Non-contrast transcatheter aortic valve implantation for patients with aortic stenosis and chronic kidney disease: a pilot study","volume":"10","author":"Freire","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/S0140-6736(24)00821-3","article-title":"LANDMARK comparison of early outcomes of newer-generation MyVal transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial","volume":"403","author":"Baumbach","year":"2024","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4244\/EIJ-D-19-00413","article-title":"First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in patients with severe symptomatic native aortic stenosis: the MyVal-1 study","volume":"16","author":"Sharma","year":"2020","journal-title":"EuroIntervention"},{"key":"B13","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"B14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.hlc.2023.11.018","article-title":"Acute kidney injury following transcatheter aortic valve implantation\u2014a contemporary perspective of incidence, predictors, and outcomes","volume":"33","author":"Butala","year":"2024","journal-title":"Heart Lung Circ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"100038","DOI":"10.1016\/j.jscai.2022.100038","article-title":"Renal function-based contrast threshold predicts kidney injury in transcatheter aortic valve replacement","volume":"1","author":"Gualano","year":"2022","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"B16","doi-asserted-by":"publisher","first-page":"102237","DOI":"10.1016\/j.jscai.2024.102237","article-title":"A novel protocol for contrast-free transcatheter aortic valve replacement evaluation and implantation","volume":"3","author":"Elison","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.3390\/jcm13185405","article-title":"Zero-contrast transcatheter aortic valve implantation vs. standard practice: periprocedural and long-term clinical outcomes","volume":"13","author":"Nerla","year":"2024","journal-title":"J Clin Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jacc.2025.10.076","article-title":"1-year outcomes of novel balloon-expandable vs contemporary transcatheter heart valves in severe aortic stenosis: the LANDMARK trial","volume":"87","author":"Serruys","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5114\/aoms\/176937","article-title":"Clinical outcomes of the MyVal transcatheter heart valve system in patients with severe aortic valve stenosis: a two-year follow-up observational study","volume":"20","author":"Kilic","year":"2024","journal-title":"Arch Med Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.21037\/acs-2023-aae-0166","article-title":"Prosthesis-patient mismatch in transcatheter and surgical aortic valve replacement","volume":"13","author":"Hahn","year":"2024","journal-title":"Ann Cardiothorac Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"qyae040","DOI":"10.1093\/ehjimp\/qyae040","article-title":"Paravalvular regurgitation after transcatheter aortic valve replacement: incidence, quantification, and prognostic impact","volume":"2","author":"van Wely","year":"2024","journal-title":"Eur Heart J Imaging Methods Pract"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1878620\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:03:31Z","timestamp":1787724211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1878620\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":21,"alternative-id":["10.3389\/fcvm.2026.1878620"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1878620","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"1878620"}}